Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Lautner

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
JAMA Neurology|January 13, 2015
Laboratory testing for lyme neuroborreliosisRonald Lautner, Henrik Zetterberg, Kaj Blennow
Advances in Clinical Chemistry|September 20, 2014
CSF in Alzheimer's diseaseHenrik Zetterberg, Ronald Lautner, Tobias Skillbäck, et al.
International Journal of Alzheimer'S Disease|November 25, 2011
Biomarkers for microglial activation in Alzheimer's diseaseRonald Lautner, Niklas Mattsson, Michael Schöll, et al.
Brain Injury|July 9, 2016
Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold divingMagnus Gren, Pashtun Shahim, Ronald Lautner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 11, 2012
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's diseaseJonny Daborg, Ulf Andreasson, Marcela Pekna, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2013
Plasma amyloid-β in patients with Tangier diseasePashtun Shahim, Andrea E Bochem, Niklas Mattsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 18, 2018
Apolipoprotein E genotypes and longevity across dementia disordersTobias Skillbäck, Ronald Lautner, Niklas Mattsson, et al.
Journal of Alzheimer'S Disease : JAD|August 15, 2012
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementiaBob Olsson, Joakim Hertze, Ronald Lautner, et al.
The Lancet. Neurology|April 13, 2016
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisBob Olsson, Ronald Lautner, Ulf Andreasson, et al.
Alzheimer'S Research & Therapy|October 25, 2017
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrationsRonald Lautner, Philip S Insel, Tobias Skillbäck, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JAMA Neurology|January 13, 2015
Laboratory testing for lyme neuroborreliosisRonald Lautner, Henrik Zetterberg, Kaj Blennow
Advances in Clinical Chemistry|September 20, 2014
CSF in Alzheimer's diseaseHenrik Zetterberg, Ronald Lautner, Tobias Skillbäck, et al.
International Journal of Alzheimer'S Disease|November 25, 2011
Biomarkers for microglial activation in Alzheimer's diseaseRonald Lautner, Niklas Mattsson, Michael Schöll, et al.
Brain Injury|July 9, 2016
Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold divingMagnus Gren, Pashtun Shahim, Ronald Lautner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 11, 2012
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's diseaseJonny Daborg, Ulf Andreasson, Marcela Pekna, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2013
Plasma amyloid-β in patients with Tangier diseasePashtun Shahim, Andrea E Bochem, Niklas Mattsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 18, 2018
Apolipoprotein E genotypes and longevity across dementia disordersTobias Skillbäck, Ronald Lautner, Niklas Mattsson, et al.
Journal of Alzheimer'S Disease : JAD|August 15, 2012
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementiaBob Olsson, Joakim Hertze, Ronald Lautner, et al.
The Lancet. Neurology|April 13, 2016
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisBob Olsson, Ronald Lautner, Ulf Andreasson, et al.
Alzheimer'S Research & Therapy|October 25, 2017
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrationsRonald Lautner, Philip S Insel, Tobias Skillbäck, et al.
Pageof 2